SGLT-2抑制剂:叙述性回顾。

Q4 Medicine
Dawood Shehzad, Muhammad Hasan, Naveen Rajpurohit
{"title":"SGLT-2抑制剂:叙述性回顾。","authors":"Dawood Shehzad, Muhammad Hasan, Naveen Rajpurohit","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>SGLT2 inhibitors have emerged as a remarkable class of drugs, revolutionizing the management of various medical conditions beyond their initial purpose of controlling diabetes. With their proven benefits in cardiovascular health, kidney disease, hypertension, and even potential applications in cancer treatment, SGLT2 inhibitors have broadened their scope. While concerns about adverse effects and contraindications exist, these medications hold great promise for a diverse range of patients. Moreover, as generic alternatives become more accessible and affordable, the potential benefits of SGLT2 inhibitors are poised to reach a wider audience, making them a significant player in modern healthcare.</p>","PeriodicalId":39219,"journal":{"name":"South Dakota medicine : the journal of the South Dakota State Medical Association","volume":"77 9","pages":"422-426"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SGLT-2 Inhibitors: A Narrative Review.\",\"authors\":\"Dawood Shehzad, Muhammad Hasan, Naveen Rajpurohit\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>SGLT2 inhibitors have emerged as a remarkable class of drugs, revolutionizing the management of various medical conditions beyond their initial purpose of controlling diabetes. With their proven benefits in cardiovascular health, kidney disease, hypertension, and even potential applications in cancer treatment, SGLT2 inhibitors have broadened their scope. While concerns about adverse effects and contraindications exist, these medications hold great promise for a diverse range of patients. Moreover, as generic alternatives become more accessible and affordable, the potential benefits of SGLT2 inhibitors are poised to reach a wider audience, making them a significant player in modern healthcare.</p>\",\"PeriodicalId\":39219,\"journal\":{\"name\":\"South Dakota medicine : the journal of the South Dakota State Medical Association\",\"volume\":\"77 9\",\"pages\":\"422-426\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South Dakota medicine : the journal of the South Dakota State Medical Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South Dakota medicine : the journal of the South Dakota State Medical Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

SGLT2抑制剂已经成为一类引人注目的药物,它彻底改变了各种医疗条件的管理,而不仅仅是控制糖尿病的最初目的。SGLT2抑制剂在心血管健康、肾脏疾病、高血压、甚至癌症治疗方面的潜在应用已被证实具有益处,SGLT2抑制剂已拓宽了其应用范围。虽然存在对副作用和禁忌症的担忧,但这些药物对各种各样的患者都有很大的希望。此外,随着非专利替代品变得更容易获得和负担得起,SGLT2抑制剂的潜在益处有望覆盖更广泛的受众,使其成为现代医疗保健中的重要参与者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
SGLT-2 Inhibitors: A Narrative Review.

SGLT2 inhibitors have emerged as a remarkable class of drugs, revolutionizing the management of various medical conditions beyond their initial purpose of controlling diabetes. With their proven benefits in cardiovascular health, kidney disease, hypertension, and even potential applications in cancer treatment, SGLT2 inhibitors have broadened their scope. While concerns about adverse effects and contraindications exist, these medications hold great promise for a diverse range of patients. Moreover, as generic alternatives become more accessible and affordable, the potential benefits of SGLT2 inhibitors are poised to reach a wider audience, making them a significant player in modern healthcare.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
62
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信